L-theanine

L-theanine is a non-protein amino acid that occurs naturally in tea leaves (Camellia sinensis) and a small number of other plant sources. It is structurally similar to the neurotransmitter glutamate and to glutamine, and it is the amino acid believed to contribute to the characteristic taste of tea and to the subjective sense of "alert calm" sometimes associated with green tea consumption.¹ L-theanine is the form that occurs naturally and is the form used in commercial supplements; the related D-theanine isomer is rare in nature and is not used clinically.

Mechanistically, L-theanine is thought to cross the blood-brain barrier and to modulate several neurotransmitter systems including glutamatergic, gabaergic, dopaminergic, and serotonergic pathways, and to increase alpha-wave activity on electroencephalogram — a pattern associated with a state of relaxed alertness.¹²

L-theanine has been studied primarily for effects on stress, anxiety, sleep quality, and cognitive performance in healthy adults under stressful conditions.

A 2020 PRISMA-guided systematic review of L-theanine supplementation in randomized human trials, conducted by Williams and colleagues, included 9 studies and concluded that supplementation of 200–400 mg/day may assist in the reduction of stress and anxiety in people exposed to stressful conditions.¹ A subsequent narrative review of L-theanine's psychotropic effects similarly summarized that daily doses of 200–400 mg appear safe and produce anxiolytic and anti-stress effects in both acute and chronic settings, while noting that larger and longer trials are still needed to firmly establish clinical recommendations.²

L-theanine has also been studied in combination with caffeine, with several small studies suggesting that the combination may improve attention and reduce some of the subjective jitteriness associated with caffeine alone, although evidence quality varies and effects are typically modest.²

Beyond healthy populations, L-theanine has been investigated as an adjunctive treatment in several psychiatric conditions including generalized anxiety disorder, schizophrenia, and attention-deficit/hyperactivity disorder; results have generally been preliminary but supportive of further study.¹

The clinical research base most consistently reports outcomes at 200–400 mg/day, typically administered as a single dose or split into two doses.¹² Commercial supplements are commonly sold in 100 mg, 200 mg, and 250 mg capsule strengths. A standard cup of green tea provides on the order of 25–60 mg of L-theanine, depending on the variety and preparation, so dietary intake from tea typically does not reach the levels used in clinical studies.²

The U.S. Food and Drug Administration has granted Generally Recognized as Safe (GRAS) status to L-theanine for use in food products at specified levels. No Tolerable Upper Intake Level has been established, and the available clinical literature has not identified a specific dose-related toxicity threshold within the studied range.¹

Oral, as capsules, tablets, chewables, or as an ingredient in functional beverages.

Standard storage in a cool, dry place out of direct sunlight.

L-theanine is generally well-tolerated in the studied dose range. Reported side effects across clinical trials have been infrequent and mild, with no consistent pattern of significant adverse events at doses up to 400 mg/day for periods up to 8 weeks.¹ Headache and gastrointestinal symptoms have been occasionally reported.

A few practical considerations:¹

• Blood pressure: Some studies have reported small reductions in blood pressure with L-theanine, which is generally not clinically meaningful in healthy individuals but is a consideration in individuals taking antihypertensive medications.
• CNS depressants: Combining L-theanine with sedating medications has not been extensively studied; theoretical additive effects on relaxation or sedation are plausible.
• Stimulants: When combined with caffeine, the subjective profile may shift toward calmer focus, but the underlying stimulant effect on cardiovascular parameters is not eliminated.
• Pregnancy and lactation: Insufficient safety data exist for use during pregnancy or breastfeeding; use during these periods should involve clinician discussion.

Long-term safety data beyond approximately 8 weeks of continuous supplementation are limited, and the long-term consequences of daily L-theanine supplementation are not fully characterized in published trials.¹